Clinical Trials · NCT03472846
MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Medical University of Vienna
- Enrollment
- 26
- Start date
- Mar 2017
- Locations
- 1 site, Austria
- Primary endpoint
- detection of microRNA concentration in serum